FDA Rejects Xeljanz Expanded Use for Plaque Psoriasis


Pfizer asked to provide additional safety analyses for proposed indication.

Pfizer asked to provide additional safety analyses for proposed indication.

The FDA has rejected Pfizer’s supplemental new drug application to expand the use of tofacitinib citrate (Xeljanz).

Pfizer sought to expand the use of Xeljanz, now used as a treatment for rheumatoid arthritis, to treat moderate to severe plaque psoriasis in adult patients.

The FDA’s complete response letter, which was sent to Pfizer, is given to a company when a product cannot be approved in its present form.

While the FDA did not approve the expanded indication, the administration did provide recommendations, including that Pfizer provide additional safety analyses for the proposed indication.

“Pfizer remains committed to Xeljanz based on the strength of the clinical data for the treatment of psoriasis,” said Kenneth Verburg, senior vice president and head of global medicines development, Global Innovative Pharma Business, in a press release. “It is our goal to work closely with the FDA to understand and address their comments about our filing for the use of Xeljanz in patients with chronic plaque psoriasis.”

Adverse effects related to Xeljanz include upper respiratory tract infection, headache, diarrhea, and nasal congestion.

Related Videos
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
pharmacy | Image Credit: Diego Cervo - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.